GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
Related News
GWPH
As of {tag_as of date}
GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
Related News
11-Apr-2019
Attorney General Barr: US law protecting state-legal marijuana trumps current situation read more -->
10-Apr-2019
The STATES Act Is Back. Can It Win Over Congress? read more -->
01-Apr-2019
Cannabis banking bill advances in committee; full US House vote expected within weeks read more -->
28-Mar-2019
Guam’s Senate approves legal foundation for adult-use cannabis industry read more-->
